Skip to main content
Erschienen in: Spektrum der Augenheilkunde 3/2013

01.06.2013 | kommissionsbericht

Empfehlungen der NH Kommission der ÖOG zur Durchführung einer IVOM (intravitreale operative Medikamentenapplikation) Oktober 2012

verfasst von: Univ.-Prof. Dr. Gerhard Kieselbach

Erschienen in: Spektrum der Augenheilkunde | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Auszug

Die IVOM (intravitreale operative Medikamentenapplikation) hat sich in der Behandlung vitreoretinaler Erkrankungen als minimalinvasiver Eingriff etabliert. Schwerwiegende Komplikationen können auftreten, sind jedoch selten [1, 20, 10, 15, 16]. …
Literatur
1.
Zurück zum Zitat Aiello LP, Brucker AJ, Chang S, Cunningham ET, D’Amico DJ, Flynn HW, Grillone LR, Hutcherson S, Liebmann JM, O’Brien TP, Scott IU, Spaide RF, Ta C, Trese MT.Evolving guidelines for intravitreous injections. Retina. 2004;24:S 3–19.CrossRef Aiello LP, Brucker AJ, Chang S, Cunningham ET, D’Amico DJ, Flynn HW, Grillone LR, Hutcherson S, Liebmann JM, O’Brien TP, Scott IU, Spaide RF, Ta C, Trese MT.Evolving guidelines for intravitreous injections. Retina. 2004;24:S 3–19.CrossRef
2.
Zurück zum Zitat Apt L, Isenberg S, Yoshimori R, Paez JH.Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728–9.PubMedCrossRef Apt L, Isenberg S, Yoshimori R, Paez JH.Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728–9.PubMedCrossRef
3.
Zurück zum Zitat Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.; Arch Ophthalmol. 2012 Jun;130(6):809–10.PubMedCrossRef Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.; Arch Ophthalmol. 2012 Jun;130(6):809–10.PubMedCrossRef
4.
Zurück zum Zitat Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012 Aug;119(8):1609–14.PubMedCrossRef Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012 Aug;119(8):1609–14.PubMedCrossRef
5.
Zurück zum Zitat Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol. 2004;88:1131–6.PubMedCrossRef Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol. 2004;88:1131–6.PubMedCrossRef
6.
Zurück zum Zitat De Kaspar HM, Chang R, Egbert P. Greater elimination of conjunctiva bacteria after preoperative irrigation with 10 cc of 5 % povidone-iodine. Presented at: Annual Meeting of the American Academy of Ophthalmology. November 15–18, 2003; Anaheim, Florida De Kaspar HM, Chang R, Egbert P. Greater elimination of conjunctiva bacteria after preoperative irrigation with 10 cc of 5 % povidone-iodine. Presented at: Annual Meeting of the American Academy of Ophthalmology. November 15–18, 2003; Anaheim, Florida
7.
Zurück zum Zitat De Kaspar HM, Shriver EM, Nguyen EV, Egbert PR, Singh K, Blumenkranz MS, Ta CN. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefe’s Arch Clin Exp Ophthalmol 2003;241:730–3.CrossRef De Kaspar HM, Shriver EM, Nguyen EV, Egbert PR, Singh K, Blumenkranz MS, Ta CN. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefe’s Arch Clin Exp Ophthalmol 2003;241:730–3.CrossRef
8.
Zurück zum Zitat Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5 % Povidone-Iodine solution against 1 % Povidone-Iodine solution in preoperative cataract surgery antisepsis: a prospective randomiseddouble blind study. Br J Ophthalmol 2003;87:163–7.PubMedCrossRef Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5 % Povidone-Iodine solution against 1 % Povidone-Iodine solution in preoperative cataract surgery antisepsis: a prospective randomiseddouble blind study. Br J Ophthalmol 2003;87:163–7.PubMedCrossRef
9.
Zurück zum Zitat Flynn HW, Scott IU.Introduction. Intravitreal injections: The route of retinal pharmacotherapies. Retina. 2004;24:S 1CrossRef Flynn HW, Scott IU.Introduction. Intravitreal injections: The route of retinal pharmacotherapies. Retina. 2004;24:S 1CrossRef
10.
Zurück zum Zitat Jaissle GB & Bartz-Schmidt KU. Empfehlung der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands für die Durchführung von intravitrealen Injektionen April 2007 (www.retinologie.org) Jaissle GB & Bartz-Schmidt KU. Empfehlung der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands für die Durchführung von intravitrealen Injektionen April 2007 (www.retinologie.org)
11.
Zurück zum Zitat Keverline MR, Kowalski RP, Dhaliwal DK. In vitro comparison of Ciprofloxacin, Ofloxacin, and Povidone-Iodine for surgical propyhlaxis. J Cataract Refract surg. 2002;28:915–6.PubMedCrossRef Keverline MR, Kowalski RP, Dhaliwal DK. In vitro comparison of Ciprofloxacin, Ofloxacin, and Povidone-Iodine for surgical propyhlaxis. J Cataract Refract surg. 2002;28:915–6.PubMedCrossRef
12.
Zurück zum Zitat Kim SJ, et al. Ophthalmic antibiotics and antimicrobial resistance, a randomized, controlled study of patients undergoing intravitreal injections, Ophthalmology 2011. Kim SJ, et al. Ophthalmic antibiotics and antimicrobial resistance, a randomized, controlled study of patients undergoing intravitreal injections, Ophthalmology 2011.
13.
Zurück zum Zitat Moshfeghi AA, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center, Retina 2011;31:662–8.PubMedCrossRef Moshfeghi AA, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center, Retina 2011;31:662–8.PubMedCrossRef
14.
Zurück zum Zitat Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul;119(7):1388–98. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul;119(7):1388–98.
15.
Zurück zum Zitat Speaker MG, Menikoff JA.Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769–75.PubMed Speaker MG, Menikoff JA.Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769–75.PubMed
16.
Zurück zum Zitat Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN.Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639–49. (discussion 650)PubMed Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN.Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639–49. (discussion 650)PubMed
17.
Zurück zum Zitat Starr MB, Lally JM. Antimicrobial prophylaxis for ophthalmic surgery. SurvOphthalmol 1995;39:485–501.PubMedCrossRef Starr MB, Lally JM. Antimicrobial prophylaxis for ophthalmic surgery. SurvOphthalmol 1995;39:485–501.PubMedCrossRef
18.
Zurück zum Zitat Sutter FKP, Gillies MC.Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment. Results from a randomized clinical trial: TDMO. Invest Ophthalmol Vis Sci 2003;44:454. (ARVO EAbstract) Sutter FKP, Gillies MC.Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment. Results from a randomized clinical trial: TDMO. Invest Ophthalmol Vis Sci 2003;44:454. (ARVO EAbstract)
19.
Zurück zum Zitat Ta CN. Minimizing the risk of endophthalmitis following intravitreous injections.Retina 2004;24:699–705.PubMedCrossRef Ta CN. Minimizing the risk of endophthalmitis following intravitreous injections.Retina 2004;24:699–705.PubMedCrossRef
20.
Zurück zum Zitat Yokoyama Y, Makino S, Ibaraki N. Comparison in effectiveness of sterilization between chlorhexidine gluconate and povidone-iodine Nihon Ganka Gakkai Zasshi 2008 Feb;112(2):148–51. Yokoyama Y, Makino S, Ibaraki N. Comparison in effectiveness of sterilization between chlorhexidine gluconate and povidone-iodine Nihon Ganka Gakkai Zasshi 2008 Feb;112(2):148–51.
Metadaten
Titel
Empfehlungen der NH Kommission der ÖOG zur Durchführung einer IVOM (intravitreale operative Medikamentenapplikation) Oktober 2012
verfasst von
Univ.-Prof. Dr. Gerhard Kieselbach
Publikationsdatum
01.06.2013
Verlag
Springer Vienna
Erschienen in
Spektrum der Augenheilkunde / Ausgabe 3/2013
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI
https://doi.org/10.1007/s00717-012-0133-6

Weitere Artikel der Ausgabe 3/2013

Spektrum der Augenheilkunde 3/2013 Zur Ausgabe